APIs-Pharmaceutical Chemicals+ Inorganic Materials+ Nano Materials

Products >> Organic >> APIs

Product name
Product No.
Molecular Formula
Usage
C10H13N5O4
A synthetic thymine nucleoside antiviral drug used for the treatment of acquired immunodeficiency syndrome (AIDS).
C17H14N2O6S
An anti rheumatic agent, which can effectively inhibit the activity of COX-2; Macrophage migration inhibitory factor (MIF) inhibitor
C13H19N5.H2O
An antihypertensive drug is a potassium channel activator.
C22H23ClFN5O3
An EGFP inhibitor (Epidermal growth factor receptor tyrosine kinase inhibitor) with blood brain barrier (BBB) penetration. It has the potential for the treatment of non-small cell lung cancer (NSCLC), with brain metastases (BM) and leptomengingeal metastases (LM) since this type of cancer often contain a lot of activating mutations of the epidermal growth factor receptor (EGFR).
C22H30Cl2N4O6
Antineoplastic drugs. It is an inhibitor of type II toposomerase and protein kinase C (PKC), which can inhibit the proliferation of MCF-7 / WT cells and induce apoptosis.
C13H11N3O4
Immuno-modulatorydrug
C8H11N3O3S
A novel antiviral drug, is a nucleoside reverse transcriptase inhibitor
C19H21N3O5
A long-acting calcium blocker effective in the treatment of essential hypertension.
C14H8ClNO4.2Na
An antiinflammatory agent useful in the treatment of rheumatoid arthritis, especially that of recent onset.
C19H15ClN2O4
A new anti ulcer drug
C23H33NO7S2
A novel selective cytokine inhibitor
C14H22ClN3O2
Dopamine D2 receptor blocker can block the D2 receptor in the chemoemetic receptor area (CTZ) of the medulla oblongata and produce a strong central antiemetic effect. It is used to treat vomiting caused by many reasons
C6H10N2O3
Brain metabolism improving drugs, pyrrolidone derivatives, can improve the memory and learning function of patients with senile dementia and memory impairment.
C24H34N4O5S
The third generation sulfonylurea long-acting antidiabetic drugs
C23H28F2N6O4S
It is the first reversible binding oral P2Y12 adenosine diphosphate receptor antagonist in the world. It can reversibly act on purinoceptor2 (P2) subtype p2chemicalbooky12 on vascular smooth muscle cells (VSMC), and can effectively improve the symptoms of patients with acute coronary heart disease.
Total: 387 Page: 6 / 26 First ←Previous Next→ End
WechatClose
Wechat